These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

959 related items for PubMed ID: 30073292

  • 1. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    Lee S, Kim BJ, Lee YB, Lee WS.
    JAMA Dermatol; 2018 Oct 01; 154(10):1145-1151. PubMed ID: 30073292
    [Abstract] [Full Text] [Related]

  • 2. Treatments for alopecia areata: a network meta-analysis.
    Mateos-Haro M, Novoa-Candia M, Sánchez Vanegas G, Correa-Pérez A, Gaetano Gil A, Fernández-García S, Ortega-Quijano D, Urueña Rodriguez MG, Saceda-Corralo D, Bennouna-Dalero T, Giraldo L, Tomlinson J, Vaño-Galván S, Zamora J.
    Cochrane Database Syst Rev; 2023 Oct 23; 10(10):CD013719. PubMed ID: 37870096
    [Abstract] [Full Text] [Related]

  • 3. Alopecia areata in children: treatment with diphencyprone.
    Schuttelaar ML, Hamstra JJ, Plinck EP, Peereboom-Wynia JD, Vuzevski VD, Mulder PG, Oranje AP.
    Br J Dermatol; 1996 Oct 23; 135(4):581-5. PubMed ID: 8915150
    [Abstract] [Full Text] [Related]

  • 4. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
    Morita K, Nakamura M, Nagamachi M, Kishi T, Miyachi Y.
    J Dermatol; 2002 Oct 23; 29(10):661-4. PubMed ID: 12433000
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The pattern and profile of alopecia areata in Singapore--a study of 219 Asians.
    Tan E, Tay YK, Goh CL, Chin Giam Y.
    Int J Dermatol; 2002 Nov 23; 41(11):748-53. PubMed ID: 12452996
    [Abstract] [Full Text] [Related]

  • 7. Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata: Retrospective analysis of 159 cases.
    Choe SJ, Lee S, Pi LQ, Keum DI, Lee CH, Kim BJ, Lee WS.
    J Am Acad Dermatol; 2018 Mar 23; 78(3):515-521.e4. PubMed ID: 29108907
    [Abstract] [Full Text] [Related]

  • 8. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
    Chiang KS, Mesinkovska NA, Piliang MP, Bergfeld WF.
    J Investig Dermatol Symp Proc; 2015 Nov 23; 17(2):50-5. PubMed ID: 26551948
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Durdu M, Özcan D, Baba M, Seçkin D.
    J Am Acad Dermatol; 2015 Apr 23; 72(4):640-50. PubMed ID: 25653027
    [Abstract] [Full Text] [Related]

  • 10. Is methotrexate an effective and safe treatment for maintaining hair regrowth in people with alopecia totalis? A Critically Appraised Topic.
    Browne R, Stewart L, Williams HC.
    Br J Dermatol; 2018 Sep 23; 179(3):609-614. PubMed ID: 29777625
    [Abstract] [Full Text] [Related]

  • 11. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
    Chua SH, Goh CL, Ang CB.
    Ann Acad Med Singap; 1996 Nov 23; 25(6):842-7. PubMed ID: 9055014
    [Abstract] [Full Text] [Related]

  • 12. Topographic Phenotypes of Alopecia Areata and Development of a Prognostic Prediction Model and Grading System: A Cluster Analysis.
    Lee S, Kim BJ, Lee CH, Lee WS.
    JAMA Dermatol; 2019 May 01; 155(5):564-571. PubMed ID: 30916724
    [Abstract] [Full Text] [Related]

  • 13. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D, Patsatsi A, Lazaridou E, Kastanis A, Vakirlis E, Chrysomallis F.
    Clin Exp Dermatol; 2007 Jan 01; 32(1):48-51. PubMed ID: 17004987
    [Abstract] [Full Text] [Related]

  • 14. Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow-up period of 19 months.
    van der Steen PH, Boezeman JB, Happle R.
    Dermatology; 1992 Jan 01; 184(3):198-201. PubMed ID: 1392112
    [Abstract] [Full Text] [Related]

  • 15. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S, Freyschmidt-Paul P, Hoffmann R, Sundberg JP, Happle R, Lindsey NJ, Tobin DJ.
    Eur J Dermatol; 2000 Aug 01; 10(6):443-50. PubMed ID: 10980465
    [Abstract] [Full Text] [Related]

  • 16. DPCP for the treatment of alopecia areata.
    Bolduc C, Shapiro J.
    Skin Therapy Lett; 2000 Aug 01; 5(5):3-4. PubMed ID: 10854342
    [Abstract] [Full Text] [Related]

  • 17. Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evaluation.
    Losol E, Şentürk N.
    Dermatol Ther; 2021 Jan 01; 34(1):e14726. PubMed ID: 33377267
    [Abstract] [Full Text] [Related]

  • 18. Modified immunotherapy for alopecia areata.
    Yoshimasu T, Furukawa F.
    Autoimmun Rev; 2016 Jul 01; 15(7):664-7. PubMed ID: 26932732
    [Abstract] [Full Text] [Related]

  • 19. Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.
    Tobin DJ, Gardner SH, Lindsey NJ, Hoffmann R, Happle R, Freyschmidt-Paul P.
    Eur J Dermatol; 2002 Jul 01; 12(4):327-34. PubMed ID: 12095876
    [Abstract] [Full Text] [Related]

  • 20. Topical immunotherapy in combination with anthralin in the treatment of refractory alopecia areata.
    Kagami S, Kishi Y, Hino H.
    J Cosmet Dermatol; 2020 Sep 01; 19(9):2411-2414. PubMed ID: 32621407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.